Barriers to the Implementation of Complete Insulin Order Sets

This study has been completed.
Sponsor:
Collaborators:
International Diabetes Center at Park Nicollet
Park Nicollet Foundation
Information provided by:
Park Nicollet Institute
ClinicalTrials.gov Identifier:
NCT00813280
First received: December 19, 2008
Last updated: December 22, 2008
Last verified: December 2008
  Purpose

The major purpose of this Quality Improvement project is to begin to address the issues surrounding glycemic control in the hospital setting by collecting accurate, reliable and verifiable data on the occurrence of hyperglycemia (BG >300 mg/dL), and whether or not CIO is used (immediately before and 72 hours after the BG >300 mg/dl).


Condition
Hyperglycemia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Barriers to the Implementation of Complete Insulin Order Sets in the Management of Individuals With Hyperglycemia or Diabetes at Park Nicollet Methodist Hospital

Resource links provided by NLM:


Further study details as provided by Park Nicollet Institute:

Primary Outcome Measures:
  • glucose levels [ Time Frame: 72 hours ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • type of insulin treatment [ Time Frame: 72 hours ] [ Designated as safety issue: Yes ]

Enrollment: 200
Study Start Date: June 2008
Study Completion Date: December 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
hyperglycemia
hospitalized patients with BG >300 ml/dL

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

hospitalized patients with blood glucose >300 mg/dL

Criteria

Inclusion Criteria:

  • Park Nicollet Methodist Hospital patient
  • recorded BG > 300 mg/dL during the study data collection period
  • admitted to general floor hospital units

Exclusion Criteria:

  • birth center
  • intensive care units
  • eating disorder unit
  • pediatric patients < 18 years of age
  • patients receiving insulin infusions
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00813280

Locations
United States, Minnesota
Park Nicollet Methodist Hospital
Minneapolis, Minnesota, United States, 55416
Sponsors and Collaborators
Park Nicollet Institute
International Diabetes Center at Park Nicollet
Park Nicollet Foundation
Investigators
Principal Investigator: Lisa Fish, MD Park Nicollet Health Services Endocrinology
Principal Investigator: Robert M Cuddihy, MD International Diabetes Center at Park Nicollet
  More Information

Publications:
Responsible Party: Lisa Fish, MD
ClinicalTrials.gov Identifier: NCT00813280     History of Changes
Other Study ID Numbers: 03735-08-A
Study First Received: December 19, 2008
Last Updated: December 22, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hyperglycemia
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on September 18, 2014